Literature DB >> 23608926

Extent and reporting of patient nonenrollment in influential randomized clinical trials, 2002 to 2010.

Keith Humphreys, Natalya C Maisel, Janet C Blodgett, Ingrid L Fuh, John W Finney.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23608926      PMCID： PMC3963396          DOI： 10.1001/jamainternmed.2013.496

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  9 in total

Review 1.  Ineligibility and refusal to participate in randomised trials of treatments for drug dependence.

Authors:  Hans O Melberg; Keith Humphreys
Journal:  Drug Alcohol Rev       Date:  2010-03

2.  Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies.

Authors:  K Humphreys; C Weisner
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

3.  Tying clinical research to patient care by use of an observational database.

Authors:  M A Hlatky; K L Lee; F E Harrell; R M Califf; D B Pryor; D B Mark; R A Rosati
Journal:  Stat Med       Date:  1984 Oct-Dec       Impact factor: 2.373

4.  Recruitment of depressive patients for a controlled clinical trial in a psychiatric practice.

Authors:  E M Haberfellner
Journal:  Pharmacopsychiatry       Date:  2000-07       Impact factor: 5.788

5.  How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey.

Authors:  Yann Le Strat; Jürgen Rehm; Bernard Le Foll
Journal:  Tob Control       Date:  2011-01-06       Impact factor: 7.552

6.  Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.

Authors:  Monica Gandhi; Niloufar Ameli; Peter Bacchetti; Gerald B Sharp; Audrey L French; Mary Young; Stephen J Gange; Kathryn Anastos; Susan Holman; Alexandra Levine; Ruth M Greenblatt
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

7.  Generalizability of clinical trials for alcohol dependence to community samples.

Authors:  Carlos Blanco; Mark Olfson; Mayumi Okuda; Edward V Nunes; Shang-Min Liu; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2008-06-24       Impact factor: 4.492

8.  Reporting the recruitment process in clinical trials: who are these patients and how did they get there?

Authors:  Cary P Gross; Raburn Mallory; Asefeh Heiat; Harlan M Krumholz
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

9.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  BMC Med Res Methodol       Date:  2001-04-20       Impact factor: 4.615
  9 in total
  5 in total

1.  From Pharmacovigilance to Clinical Care Optimization.

Authors:  Leo Anthony Celi; Edward Moseley; Christopher Moses; Padhraig Ryan; Melek Somai; David Stone; Kai-Ou Tang
Journal:  Big Data       Date:  2014-09-01       Impact factor: 2.128

2.  Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders.

Authors:  Keith Humphreys; Natalya C Maisel; Janet C Blodgett; John W Finney
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

3.  Estimation of Population Average Treatment Effects in the FIRST Trial: Application of a Propensity Score-Based Stratification Approach.

Authors:  Jeanette W Chung; Karl Y Bilimoria; Jonah J Stulberg; Christopher M Quinn; Larry V Hedges
Journal:  Health Serv Res       Date:  2017-08-21       Impact factor: 3.402

4.  Disrupting Electronic Health Records Systems: The Next Generation.

Authors:  Leo Anthony Celi; Jeffrey David Marshall; Yuan Lai; David J Stone
Journal:  JMIR Med Inform       Date:  2015-10-23

5.  Pharmacist and patient perspectives on recruitment strategies for randomized controlled trials: a qualitative analysis.

Authors:  Jane M Fletcher; Terry Saunders-Smith; Braden J Manns; Ross Tsuyuki; Brenda R Hemmelgarn; Marcello Tonelli; David J T Campbell
Journal:  BMC Med Res Methodol       Date:  2020-10-31       Impact factor: 4.615
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.